Cabot Corporation To Expand Inkjet Facility in Haverhill, Mass.

Cabot Corporation (NYSE: CBT) announced the expansion of its Inkjet manufacturing facility in Haverhill, Massachusetts, with a new production line.

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Very Positive)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Tags

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

04/28/2022 - 09:00 AM

New Capacity to Support Growth in Digital Printing Applications

BOSTON--(BUSINESS WIRE)--

Cabot Corporation (NYSE: CBT), a leading manufacturer of pigment dispersions for digital printing today announced the expansion of its Inkjet manufacturing facility in Haverhill, Massachusetts with the addition of a new production line. The expansion will increase the company’s global capacity for color aqueous pigment dispersions and is part of an ambitious investment program of more than $50 million over the next three years to meet the growing demand of the inkjet market for digital printing applications. It is expected that the new line will be operational in 2023.

Next generation digital printing delivers unique benefits over analog printing including, greater design customization, opportunity to improve speed to market, and sustainability advantages through shorter production runs and less waste. Aqueous ink technology is the technology of choice to enable the transition from analog to digital printing in commercial and packaging applications. Cabot’s new inkjet capacity will provide a reliable global supply to support the increasing need for inkjet solutions driven by the shift to digital printing.

“As a global leader in inkjet aqueous dispersion with a broad portfolio of dispersion technologies, our investment will ensure we are able to meet the anticipated growth needs of the rapidly changing inkjet market today and in the future,” said Nick Jones, vice president and general manager, Inkjet Solutions. “We are proud to be the only company that offers both encapsulated polymer dispersion and our proprietary ‘small molecule’ technology for inkjet, enabling a higher degree of stability, flexibility and print customization for our customers. This expansion is an important step as we continue to advance our offerings and support the growth of our customers across the globe in the commercial and packaging industries.”

In addition to the expansion of the new production line, the facility recently underwent capital expansion projects including upgrades to manufacturing equipment and process technologies as part of the multi-year investment program. These upgrades enable enhanced operational efficiencies, a reduction in water usage and an increase in capacity to offer broader product portfolios for inkjet customers.

ABOUT CABOT CORPORATION

Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company, headquartered in Boston, Massachusetts. The company is a leading provider of rubber and specialty carbons, engineered elastomer composites, inkjet colorants, masterbatches and conductive compounds, fumed silica and aerogel. For more information on Cabot, please visit the company’s website at cabotcorp.com.

Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release involving the Company that are not statements of historical fact are forward-looking statements and are subject to risks and uncertainties inherent in projecting future conditions, events, and results. For a discussion of the risks and uncertainties that could cause results to differ from those expressed in the forward-looking statements, see "Risk Factors" in the Company's Annual Report on Form 10-K.